Although transcription factor YY1 regulates METTL8 expression in breast cancer cells and STAT3 transcriptionally activates METTL8 in mouse embryonic stem cells, the upstream regulator of METTL8 in GBM remains unknown [20, 21]. The gene discussed is STAT3; the disease is breast carcinoma.